The increasing prevalence of cancer, a disease in which rapid and uncontrollable cell
growth causes complication and tissue dysfunction, is one of the serious and tense concerns …

Since their discovery in the 1960s, liposomes have been studied in depth, and they continue
to constitute a field of intense research. Liposomes are valued for their biological and …

Nanoparticles have revolutionized biomedicine especially in the field of drug delivery due to
their intriguing properties such as systemic stability, level of solubility, and target site …

This review summarizes the research on phospholipids and their use for drug delivery
related to the Phospholipid Research Center Heidelberg (PRC). The focus is on projects that …

Alzheimer's disease (AD) will affect around 115 million people worldwide by the year 2050.
It is associated with the accumulation of misfolded and aggregated proteins (β-amyloid and …

Modulation of membrane lipid composition and organization is currently developing as an
effective therapeutic strategy against a wide range of diseases, including cancer. This field …

Chemotherapy is the routine treatment for cancer despite the poor efficacy and associated
off‐target toxicity. Furthermore, therapeutic doses of chemotherapeutic agents are limited …

The multidisciplinary approaches in treatment of cancer appear to be essential in term of
bringing benefits of several disciplines and their coordination in tumor elimination. Because …

In recent years, liposomes have been used in the field of biomedicine and have achieved
many significant results. Because of the unique characteristics of liposomes, there are many …

COL1A1 is an important extracellular matrix component that is associated with poor
prognosis in cancers. In this study, As1411 aptamer-conjugated liposomes were used for …